These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

59 related items for PubMed ID: 7488102

  • 1. Ornithine decarboxylase induction during liver regeneration in IRS-1-deficient mice.
    Furusaka A, Nishiyama M, Nishimaki H, Ogasawara Y, Tamemoto H, Yamauchi T, Tobe K, Kadowaki T, Tanaka T.
    Biochem Biophys Res Commun; 1995 Nov 02; 216(1):284-90. PubMed ID: 7488102
    [Abstract] [Full Text] [Related]

  • 2. Insulin receptor substrate-4 signaling in quiescent rat hepatocytes and in regenerating rat liver.
    Escribano O, Fernández-Moreno MD, Zueco JA, Menor C, Fueyo J, Ropero RM, Diaz-Laviada I, Román ID, Guijarro LG.
    Hepatology; 2003 Jun 02; 37(6):1461-9. PubMed ID: 12774026
    [Abstract] [Full Text] [Related]

  • 3. Prolonged ornithine decarboxylase induction in regenerating carcinogen-treated liver.
    Olson JW, Russell DH.
    Cancer Res; 1980 Dec 02; 40(12):4373-80. PubMed ID: 6108160
    [Abstract] [Full Text] [Related]

  • 4. Effect of retinoic acid on transglutaminase and ornithine decarboxylase activities during liver regeneration.
    Ohtake Y, Maruko A, Ohishi N, Kawaguchi M, Satoh T, Ohkubo Y.
    Cell Biochem Funct; 2008 Apr 02; 26(3):359-65. PubMed ID: 18008394
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase.
    Gupta S, Ahmad N, Mohan RR, Husain MM, Mukhtar H.
    Cancer Res; 1999 May 01; 59(9):2115-20. PubMed ID: 10232597
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Regulatory effects of corticosterone on ornithine decarboxylase activity during liver regeneration in rats.
    Ning Q, Li C, Wei K, He J, Xu C, Shao Q.
    J Gastroenterol Hepatol; 2007 Nov 01; 22(11):1978-82. PubMed ID: 17914980
    [Abstract] [Full Text] [Related]

  • 9. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM, Pegg AE.
    Cancer Res; 1998 Jul 01; 58(13):2748-53. PubMed ID: 9661886
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPARgamma agonist restores normal cell signaling and differentiation.
    Sentinelli F, Filippi E, Cavallo MG, Romeo S, Fanelli M, Baroni MG.
    J Endocrinol; 2006 Feb 01; 188(2):271-85. PubMed ID: 16461553
    [Abstract] [Full Text] [Related]

  • 13. Combination of insulinomimetic agents H2O2 and vanadate enhances insulin receptor mediated tyrosine phosphorylation of IRS-1 leading to IRS-1 association with the phosphatidylinositol 3-kinase.
    Wilden PA, Broadway D.
    J Cell Biochem; 1995 Jul 01; 58(3):279-91. PubMed ID: 7593251
    [Abstract] [Full Text] [Related]

  • 14. ATP-sensitive K+ channel-mediated glucose uptake is independent of IRS-1/phosphatidylinositol 3-kinase signaling.
    Minami K, Morita M, Saraya A, Yano H, Terauchi Y, Miki T, Kuriyama T, Kadowaki T, Seino S.
    Am J Physiol Endocrinol Metab; 2003 Dec 01; 285(6):E1289-96. PubMed ID: 12933351
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of induction of ornithine decarboxylase activity in tracheal epithelial cells by asbestiform minerals.
    Marsh JP, Mossman BT.
    Cancer Res; 1988 Feb 01; 48(3):709-14. PubMed ID: 3335033
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.
    Kido Y, Burks DJ, Withers D, Bruning JC, Kahn CR, White MF, Accili D.
    J Clin Invest; 2000 Jan 01; 105(2):199-205. PubMed ID: 10642598
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.